There are also differences in metastatic potential of breast carcinoma according to the hormonal and HER-2-status with predilection: HER2 status showed that within HER2-positive breast cancers, ER-positive/PR-positive ones still manifest better survival than the other three HR status subgroups, which are similar in survival outcomes [14]. The gene discussed is ERBB2; the disease is breast cancer.